http://rdf.ncbi.nlm.nih.gov/pubchem/patent/LV-14075-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22e9625a2559869baa1d7376652835fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d60d74136ff10e3195b7709c7426dc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e9feed60f293a6726eeeef871da1acd
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08
filingDate 2009-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d13c497188b7b776d5e912ee473e0425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0216f7b6d22fdae6d9fd8e7d3a4bcfa0
publicationDate 2010-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber LV-14075-A
titleOfInvention Bronchial beta-receptor sensitivity restoring agent for prolonged resistance to obstruction
abstract The invention relates to medicine, in particular to the treatment of chronically inflammatory respiratory pathology, especially in the case of bronchial obstruction (obstruction). The invention describes a method for restoring bronchial permeability in case of prolonged resistance to obstruction. The method involves the use of beta-agonists and corticosteroids, which are supplemented with 200 mcg of selenium per day (orally) for 5-6 months.
priorityDate 2009-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6326970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559218

Total number of triples: 16.